# A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

> **NCT07154823** · — · RECRUITING · sponsor: **Tempus AI** · enrollment: 550 (estimated)

## Conditions studied

- Acute Myeloid Leukaemia (AML)
- Follicular Lymphoma ( FL)

## Interventions

- **OTHER:** None - Observational Study

## Key facts

- **NCT ID:** NCT07154823
- **Lead sponsor:** Tempus AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2034-11
- **Final completion:** 2035-11
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154823, "A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07154823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*